Company Research
Whether you are exploring new sales opportunities or researching a new investment, FirstRain provides unique insight into important developments for Medco Health Solutions, Inc. (MHS). You can receive reports or configure the research engine for yourself.
Report On:
Medco Health Solutions, Inc. (MHS)
SERVICES - Retail - Drug Stores
Generated: Thursday September 15, 2011 04:16 AM
|
|
||||||||||||||||||
Quotes About Medco Health Solutions, Inc.
-
Rare Disease Therapeutics, Inc. Selects Accredo Health Group to Distribute Anascorp® for the Treatment of Centruroides
Rare Disease Therapeutics, Inc. has worked with Accredo for nearly ten years to provide patients with access to our potential life-saving medications for rare diseases," -
Opposition to drug plan merger grows
The market for prescription drugs, which involves often opaque interactions between insurance companies, pharmaceutical manufacturers, pharmacies, and PBMs, is complex and rapidly changing, and the impacts of this merger could be significant," -
UPDATE: FTC Urged To Closely Examine Express Scripts-Medco Deal
Although the timeline for the antitrust review process is not fixed, we are confident of a positive review and we anticipate the merger will close, as expected, in the first half of 2012,"
- Brian Henry -
NCPA reiterates opposition to proposed PBM merger before House subcommittee
The resulting merger will harm patients by reducing choice, decreasing access to pharmacy services and ultimately leading to higher prescription drug costs paid by plan sponsors and consumers," -
Pharmacy sectors hail FTC scrutiny of PBM merger
This is an important step in the careful consideration of a proposed merger that would have anticompetitive effects on patients, consumers, the market and the entire health care delivery system,"
- Douglas Hoey
No Comment
-
Medco Bulls Stuck With Losses Even On Takeover
Lowell Weiner, a spokesman for Medco, declined to comment on the regulatory process or the company's stock movement.
- Brian Henry
Latest Company Intelligence
-
US House Panel To Examine Express Scripts-Medco Deal On Sept 20
The Wall Street Journal | Sep 13,'11
WASHINGTON (Dow Jones)--A U.S. House antitrust subcommittee has scheduled a Sept. 20 hearing to review Express Scripts Inc.'s (ESRX) $29 billion deal to acquire rival Medco Health Solutions Inc. (MHS). The hearing will take place before the House Judiciary Subcommittee on Intellectual Property, Competition and the Internet. A witness list was not immediately available from the -
(FTC) Medco Health Solutions and Express Script Asked for More Information from Federal Trade Commission
Stock Market Blog | Sep 12,'11
Recently, Federal Trade Commission (FTC) requested both Medco Health Solutions ( MHS ) and Express Script ( ESRX ) to submit additional information regarding the pending acquisition deal. Under the current circumstances, the completion of the proposed acquisition can get postponed by approximately 30 days. Despite the uncertainty regarding the delay, Medco anticipates to close the -
Dems Press FTC On Express Scripts-Medco Deal
Pharmalot | Sep 12,'11
Three Democratic members of the US House are pressing the US Federal Trade Commission to conduct an in-depth analysis of the proposed $29 billion acquistion of Medco Health Solutions by Express Scripts. The move comes shortly after the agency already asked the pharmacy benefit managers for additional information about the deal, which was announced two months ago ( see this ). “If -
Opposition to drug plan merger grows
Healthwatch - The Hill | Sep 11,'11
Concern with a proposed merger of drug plan administrators is growing on Capitol Hill, with three more lawmakers urging federal regulators to give "close scrutiny" to a deal they say could force millions of Americans to pay more for their medicines. The new letter brings to at least eight the number of lawmakers of both parties who have expressed concern with the proposed merger between -
Congressmen want Medco deal scrutinized
PharmaGossip | Sep 11,'11
Express Scripts Inc.'s proposed $29.1 billion takeover of Franklin Lakes -based Medco Health Solutions Inc. merits strict scrutiny from regulators to protect consumers from higher drug costs, three Democratic U.S. House members said. The deal would affect hundreds of millions of Americans with private health insurance and may increase drug costs for government health plans, Reps. -
Medco's Latest Update on the Generic Wave
Drug Channels | Sep 8,'11
We all know about the generic wave—the unprecedented volume of brand-name drugs that will be losing exclusivity and facing generic competition over the next five years. But you may not know that Medco Health Solutions (NYSE:MHS) regularly updates and publishes its best guess about the timing of these launches. Below, I take a look at the latest projections through 2021, which show a
FirstRain customers use intelligent business search to find actionable insights about companies, management, and industries. You can review company briefs, quickly research a new idea or opportunity, generate personalized industry reports, or set up alerts on reasons to call. Be sure to view our sample reports below.
